nodes	percent_of_prediction	percent_of_DWPC	metapath
Mitoxantrone—ABCC1—Zoledronate—osteoporosis	0.15	0.232	CbGbCtD
Mitoxantrone—CYP1B1—Estradiol—osteoporosis	0.103	0.159	CbGbCtD
Mitoxantrone—ABCC1—Conjugated Estrogens—osteoporosis	0.0832	0.129	CbGbCtD
Mitoxantrone—ABCG2—Conjugated Estrogens—osteoporosis	0.0557	0.0863	CbGbCtD
Mitoxantrone—ABCG2—Estradiol—osteoporosis	0.0489	0.0757	CbGbCtD
Mitoxantrone—ABCB1—Ethinyl Estradiol—osteoporosis	0.0274	0.0424	CbGbCtD
Mitoxantrone—CYP3A4—Estropipate—osteoporosis	0.0254	0.0394	CbGbCtD
Mitoxantrone—CYP3A4—Calcitriol—osteoporosis	0.0254	0.0394	CbGbCtD
Mitoxantrone—CYP3A4—Ergocalciferol—osteoporosis	0.0203	0.0315	CbGbCtD
Mitoxantrone—ABCB1—Conjugated Estrogens—osteoporosis	0.0201	0.0311	CbGbCtD
Mitoxantrone—ABCB1—Estradiol—osteoporosis	0.0176	0.0273	CbGbCtD
Mitoxantrone—CYP3A4—Raloxifene—osteoporosis	0.017	0.0263	CbGbCtD
Mitoxantrone—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0164	0.0254	CbGbCtD
Mitoxantrone—CYP3A4—Cholecalciferol—osteoporosis	0.0131	0.0203	CbGbCtD
Mitoxantrone—CYP3A4—Conjugated Estrogens—osteoporosis	0.012	0.0186	CbGbCtD
Mitoxantrone—CYP3A4—Estradiol—osteoporosis	0.0106	0.0164	CbGbCtD
Mitoxantrone—TOP2A—Fulvestrant—Estradiol—osteoporosis	0.00106	0.337	CbGdCrCtD
Mitoxantrone—TOP2A—Levorphanol—Estradiol—osteoporosis	0.000702	0.222	CbGdCrCtD
Mitoxantrone—TOP2A—Methyltestosterone—Ethinyl Estradiol—osteoporosis	0.000641	0.203	CbGdCrCtD
Mitoxantrone—TOP2A—Norethindrone—Ethinyl Estradiol—osteoporosis	0.000418	0.132	CbGdCrCtD
Mitoxantrone—TOP2A—Levonorgestrel—Ethinyl Estradiol—osteoporosis	0.000332	0.105	CbGdCrCtD
Mitoxantrone—Shock—Risedronate—osteoporosis	0.000248	0.000929	CcSEcCtD
Mitoxantrone—Anaemia—Zoledronate—osteoporosis	0.000248	0.000929	CcSEcCtD
Mitoxantrone—Discomfort—Pamidronate—osteoporosis	0.000247	0.000925	CcSEcCtD
Mitoxantrone—Skin disorder—Risedronate—osteoporosis	0.000245	0.000917	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Calcitriol—osteoporosis	0.000245	0.000917	CcSEcCtD
Mitoxantrone—Abdominal pain—Raloxifene—osteoporosis	0.000245	0.000915	CcSEcCtD
Mitoxantrone—Body temperature increased—Raloxifene—osteoporosis	0.000245	0.000915	CcSEcCtD
Mitoxantrone—Vision blurred—Conjugated Estrogens—osteoporosis	0.000244	0.000912	CcSEcCtD
Mitoxantrone—Urticaria—Ibandronate—osteoporosis	0.000243	0.00091	CcSEcCtD
Mitoxantrone—Malaise—Zoledronate—osteoporosis	0.000242	0.000906	CcSEcCtD
Mitoxantrone—Abdominal pain—Ibandronate—osteoporosis	0.000242	0.000906	CcSEcCtD
Mitoxantrone—Body temperature increased—Ibandronate—osteoporosis	0.000242	0.000906	CcSEcCtD
Mitoxantrone—Confusional state—Pamidronate—osteoporosis	0.000242	0.000905	CcSEcCtD
Mitoxantrone—Leukopenia—Zoledronate—osteoporosis	0.00024	0.000899	CcSEcCtD
Mitoxantrone—Oedema—Pamidronate—osteoporosis	0.00024	0.000898	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Pamidronate—osteoporosis	0.00024	0.000898	CcSEcCtD
Mitoxantrone—Haemoglobin—Estradiol—osteoporosis	0.000239	0.000894	CcSEcCtD
Mitoxantrone—Infection—Pamidronate—osteoporosis	0.000238	0.000892	CcSEcCtD
Mitoxantrone—Rhinitis—Estradiol—osteoporosis	0.000238	0.000892	CcSEcCtD
Mitoxantrone—Urticaria—Calcitriol—osteoporosis	0.000238	0.000891	CcSEcCtD
Mitoxantrone—Haemorrhage—Estradiol—osteoporosis	0.000238	0.000889	CcSEcCtD
Mitoxantrone—Hepatitis—Estradiol—osteoporosis	0.000238	0.000889	CcSEcCtD
Mitoxantrone—Abdominal pain—Calcitriol—osteoporosis	0.000237	0.000887	CcSEcCtD
Mitoxantrone—Body temperature increased—Calcitriol—osteoporosis	0.000237	0.000887	CcSEcCtD
Mitoxantrone—Shock—Pamidronate—osteoporosis	0.000236	0.000883	CcSEcCtD
Mitoxantrone—Pharyngitis—Estradiol—osteoporosis	0.000236	0.000883	CcSEcCtD
Mitoxantrone—Hypersensitivity—Estropipate—osteoporosis	0.000235	0.00088	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Pamidronate—osteoporosis	0.000235	0.000879	CcSEcCtD
Mitoxantrone—Vomiting—Etidronic acid—osteoporosis	0.000235	0.000878	CcSEcCtD
Mitoxantrone—Cough—Zoledronate—osteoporosis	0.000234	0.000877	CcSEcCtD
Mitoxantrone—Tachycardia—Pamidronate—osteoporosis	0.000234	0.000876	CcSEcCtD
Mitoxantrone—Rash—Etidronic acid—osteoporosis	0.000233	0.000871	CcSEcCtD
Mitoxantrone—Convulsion—Zoledronate—osteoporosis	0.000233	0.000871	CcSEcCtD
Mitoxantrone—Dermatitis—Etidronic acid—osteoporosis	0.000233	0.00087	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Pamidronate—osteoporosis	0.000232	0.000868	CcSEcCtD
Mitoxantrone—Hypertension—Zoledronate—osteoporosis	0.000232	0.000867	CcSEcCtD
Mitoxantrone—Hypersensitivity—Alendronate—osteoporosis	0.000232	0.000867	CcSEcCtD
Mitoxantrone—Headache—Etidronic acid—osteoporosis	0.000231	0.000865	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Risedronate—osteoporosis	0.00023	0.00086	CcSEcCtD
Mitoxantrone—Asthenia—Estropipate—osteoporosis	0.000229	0.000857	CcSEcCtD
Mitoxantrone—Anorexia—Pamidronate—osteoporosis	0.000229	0.000856	CcSEcCtD
Mitoxantrone—Myalgia—Zoledronate—osteoporosis	0.000229	0.000855	CcSEcCtD
Mitoxantrone—Chest pain—Zoledronate—osteoporosis	0.000229	0.000855	CcSEcCtD
Mitoxantrone—Arthralgia—Zoledronate—osteoporosis	0.000229	0.000855	CcSEcCtD
Mitoxantrone—Anxiety—Zoledronate—osteoporosis	0.000228	0.000852	CcSEcCtD
Mitoxantrone—Paraesthesia—Risedronate—osteoporosis	0.000227	0.000848	CcSEcCtD
Mitoxantrone—Discomfort—Zoledronate—osteoporosis	0.000226	0.000845	CcSEcCtD
Mitoxantrone—Asthenia—Alendronate—osteoporosis	0.000226	0.000844	CcSEcCtD
Mitoxantrone—Hypersensitivity—Ibandronate—osteoporosis	0.000226	0.000844	CcSEcCtD
Mitoxantrone—Cough—Conjugated Estrogens—osteoporosis	0.000226	0.000844	CcSEcCtD
Mitoxantrone—Dyspnoea—Risedronate—osteoporosis	0.000225	0.000842	CcSEcCtD
Mitoxantrone—Hypotension—Pamidronate—osteoporosis	0.000224	0.000839	CcSEcCtD
Mitoxantrone—Convulsion—Conjugated Estrogens—osteoporosis	0.000224	0.000838	CcSEcCtD
Mitoxantrone—Fatigue—Ethinyl Estradiol—osteoporosis	0.000223	0.000835	CcSEcCtD
Mitoxantrone—Dyspepsia—Risedronate—osteoporosis	0.000222	0.000831	CcSEcCtD
Mitoxantrone—Constipation—Ethinyl Estradiol—osteoporosis	0.000221	0.000828	CcSEcCtD
Mitoxantrone—Confusional state—Zoledronate—osteoporosis	0.000221	0.000827	CcSEcCtD
Mitoxantrone—Hypersensitivity—Calcitriol—osteoporosis	0.000221	0.000826	CcSEcCtD
Mitoxantrone—Chest pain—Conjugated Estrogens—osteoporosis	0.00022	0.000824	CcSEcCtD
Mitoxantrone—Arthralgia—Conjugated Estrogens—osteoporosis	0.00022	0.000824	CcSEcCtD
Mitoxantrone—Myalgia—Conjugated Estrogens—osteoporosis	0.00022	0.000824	CcSEcCtD
Mitoxantrone—Asthenia—Ibandronate—osteoporosis	0.00022	0.000822	CcSEcCtD
Mitoxantrone—Anxiety—Conjugated Estrogens—osteoporosis	0.000219	0.000821	CcSEcCtD
Mitoxantrone—Nausea—Etidronic acid—osteoporosis	0.000219	0.00082	CcSEcCtD
Mitoxantrone—Oedema—Zoledronate—osteoporosis	0.000219	0.00082	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Zoledronate—osteoporosis	0.000219	0.00082	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000219	0.000818	CcSEcCtD
Mitoxantrone—Diarrhoea—Estropipate—osteoporosis	0.000219	0.000818	CcSEcCtD
Mitoxantrone—Infection—Zoledronate—osteoporosis	0.000218	0.000815	CcSEcCtD
Mitoxantrone—Fatigue—Risedronate—osteoporosis	0.000218	0.000814	CcSEcCtD
Mitoxantrone—Pain—Risedronate—osteoporosis	0.000216	0.000808	CcSEcCtD
Mitoxantrone—Constipation—Risedronate—osteoporosis	0.000216	0.000808	CcSEcCtD
Mitoxantrone—Shock—Zoledronate—osteoporosis	0.000216	0.000807	CcSEcCtD
Mitoxantrone—Paraesthesia—Pamidronate—osteoporosis	0.000215	0.000806	CcSEcCtD
Mitoxantrone—Diarrhoea—Alendronate—osteoporosis	0.000215	0.000805	CcSEcCtD
Mitoxantrone—Asthenia—Calcitriol—osteoporosis	0.000215	0.000805	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Zoledronate—osteoporosis	0.000215	0.000803	CcSEcCtD
Mitoxantrone—Dyspnoea—Pamidronate—osteoporosis	0.000214	0.0008	CcSEcCtD
Mitoxantrone—Tachycardia—Zoledronate—osteoporosis	0.000214	0.0008	CcSEcCtD
Mitoxantrone—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000213	0.000798	CcSEcCtD
Mitoxantrone—Chills—Estradiol—osteoporosis	0.000213	0.000798	CcSEcCtD
Mitoxantrone—Somnolence—Pamidronate—osteoporosis	0.000213	0.000798	CcSEcCtD
Mitoxantrone—Skin disorder—Zoledronate—osteoporosis	0.000213	0.000796	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Zoledronate—osteoporosis	0.000212	0.000793	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000212	0.000792	CcSEcCtD
Mitoxantrone—Diarrhoea—Raloxifene—osteoporosis	0.000212	0.000792	CcSEcCtD
Mitoxantrone—Dyspepsia—Pamidronate—osteoporosis	0.000211	0.00079	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000211	0.00079	CcSEcCtD
Mitoxantrone—Oedema—Conjugated Estrogens—osteoporosis	0.000211	0.00079	CcSEcCtD
Mitoxantrone—Alopecia—Estradiol—osteoporosis	0.00021	0.000786	CcSEcCtD
Mitoxantrone—Infection—Conjugated Estrogens—osteoporosis	0.00021	0.000784	CcSEcCtD
Mitoxantrone—Diarrhoea—Ibandronate—osteoporosis	0.00021	0.000784	CcSEcCtD
Mitoxantrone—Anorexia—Zoledronate—osteoporosis	0.000209	0.000782	CcSEcCtD
Mitoxantrone—Decreased appetite—Pamidronate—osteoporosis	0.000209	0.00078	CcSEcCtD
Mitoxantrone—Shock—Conjugated Estrogens—osteoporosis	0.000208	0.000777	CcSEcCtD
Mitoxantrone—Erythema—Estradiol—osteoporosis	0.000207	0.000774	CcSEcCtD
Mitoxantrone—Fatigue—Pamidronate—osteoporosis	0.000207	0.000774	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Risedronate—osteoporosis	0.000206	0.000772	CcSEcCtD
Mitoxantrone—Tachycardia—Conjugated Estrogens—osteoporosis	0.000206	0.000771	CcSEcCtD
Mitoxantrone—Urticaria—Ethinyl Estradiol—osteoporosis	0.000206	0.000769	CcSEcCtD
Mitoxantrone—Constipation—Pamidronate—osteoporosis	0.000205	0.000768	CcSEcCtD
Mitoxantrone—Pain—Pamidronate—osteoporosis	0.000205	0.000768	CcSEcCtD
Mitoxantrone—Diarrhoea—Calcitriol—osteoporosis	0.000205	0.000767	CcSEcCtD
Mitoxantrone—Skin disorder—Conjugated Estrogens—osteoporosis	0.000205	0.000767	CcSEcCtD
Mitoxantrone—Hypotension—Zoledronate—osteoporosis	0.000205	0.000766	CcSEcCtD
Mitoxantrone—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000205	0.000766	CcSEcCtD
Mitoxantrone—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000205	0.000766	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000204	0.000763	CcSEcCtD
Mitoxantrone—Vomiting—Estropipate—osteoporosis	0.000203	0.00076	CcSEcCtD
Mitoxantrone—Dysgeusia—Estradiol—osteoporosis	0.000203	0.000758	CcSEcCtD
Mitoxantrone—Rash—Estropipate—osteoporosis	0.000201	0.000753	CcSEcCtD
Mitoxantrone—Dermatitis—Estropipate—osteoporosis	0.000201	0.000753	CcSEcCtD
Mitoxantrone—Anorexia—Conjugated Estrogens—osteoporosis	0.000201	0.000753	CcSEcCtD
Mitoxantrone—Urticaria—Risedronate—osteoporosis	0.000201	0.00075	CcSEcCtD
Mitoxantrone—Back pain—Estradiol—osteoporosis	0.0002	0.000749	CcSEcCtD
Mitoxantrone—Headache—Estropipate—osteoporosis	0.0002	0.000749	CcSEcCtD
Mitoxantrone—Vomiting—Alendronate—osteoporosis	0.0002	0.000748	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.0002	0.000747	CcSEcCtD
Mitoxantrone—Abdominal pain—Risedronate—osteoporosis	0.0002	0.000747	CcSEcCtD
Mitoxantrone—Body temperature increased—Risedronate—osteoporosis	0.0002	0.000747	CcSEcCtD
Mitoxantrone—Rash—Alendronate—osteoporosis	0.000198	0.000742	CcSEcCtD
Mitoxantrone—Dermatitis—Alendronate—osteoporosis	0.000198	0.000741	CcSEcCtD
Mitoxantrone—Feeling abnormal—Pamidronate—osteoporosis	0.000198	0.00074	CcSEcCtD
Mitoxantrone—Hypotension—Conjugated Estrogens—osteoporosis	0.000197	0.000738	CcSEcCtD
Mitoxantrone—Headache—Alendronate—osteoporosis	0.000197	0.000737	CcSEcCtD
Mitoxantrone—Paraesthesia—Zoledronate—osteoporosis	0.000197	0.000736	CcSEcCtD
Mitoxantrone—Vomiting—Raloxifene—osteoporosis	0.000197	0.000736	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Pamidronate—osteoporosis	0.000196	0.000734	CcSEcCtD
Mitoxantrone—Dyspnoea—Zoledronate—osteoporosis	0.000195	0.000731	CcSEcCtD
Mitoxantrone—Rash—Raloxifene—osteoporosis	0.000195	0.00073	CcSEcCtD
Mitoxantrone—Dermatitis—Raloxifene—osteoporosis	0.000195	0.000729	CcSEcCtD
Mitoxantrone—Somnolence—Zoledronate—osteoporosis	0.000195	0.000729	CcSEcCtD
Mitoxantrone—Vomiting—Ibandronate—osteoporosis	0.000195	0.000729	CcSEcCtD
Mitoxantrone—Headache—Raloxifene—osteoporosis	0.000194	0.000725	CcSEcCtD
Mitoxantrone—Rash—Ibandronate—osteoporosis	0.000193	0.000722	CcSEcCtD
Mitoxantrone—Dermatitis—Ibandronate—osteoporosis	0.000193	0.000722	CcSEcCtD
Mitoxantrone—Dyspepsia—Zoledronate—osteoporosis	0.000193	0.000722	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000192	0.000719	CcSEcCtD
Mitoxantrone—Ill-defined disorder—Estradiol—osteoporosis	0.000192	0.000718	CcSEcCtD
Mitoxantrone—Headache—Ibandronate—osteoporosis	0.000192	0.000718	CcSEcCtD
Mitoxantrone—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000191	0.000714	CcSEcCtD
Mitoxantrone—Vomiting—Calcitriol—osteoporosis	0.000191	0.000713	CcSEcCtD
Mitoxantrone—Decreased appetite—Zoledronate—osteoporosis	0.000191	0.000713	CcSEcCtD
Mitoxantrone—Nausea—Estropipate—osteoporosis	0.00019	0.00071	CcSEcCtD
Mitoxantrone—Abdominal pain—Pamidronate—osteoporosis	0.00019	0.00071	CcSEcCtD
Mitoxantrone—Body temperature increased—Pamidronate—osteoporosis	0.00019	0.00071	CcSEcCtD
Mitoxantrone—Paraesthesia—Conjugated Estrogens—osteoporosis	0.00019	0.000709	CcSEcCtD
Mitoxantrone—Rash—Calcitriol—osteoporosis	0.000189	0.000707	CcSEcCtD
Mitoxantrone—Fatigue—Zoledronate—osteoporosis	0.000189	0.000707	CcSEcCtD
Mitoxantrone—Dermatitis—Calcitriol—osteoporosis	0.000189	0.000707	CcSEcCtD
Mitoxantrone—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000188	0.000704	CcSEcCtD
Mitoxantrone—Headache—Calcitriol—osteoporosis	0.000188	0.000703	CcSEcCtD
Mitoxantrone—Somnolence—Conjugated Estrogens—osteoporosis	0.000188	0.000702	CcSEcCtD
Mitoxantrone—Pain—Zoledronate—osteoporosis	0.000187	0.000701	CcSEcCtD
Mitoxantrone—Constipation—Zoledronate—osteoporosis	0.000187	0.000701	CcSEcCtD
Mitoxantrone—Nausea—Alendronate—osteoporosis	0.000187	0.000699	CcSEcCtD
Mitoxantrone—Malaise—Estradiol—osteoporosis	0.000187	0.000698	CcSEcCtD
Mitoxantrone—Hypersensitivity—Risedronate—osteoporosis	0.000186	0.000696	CcSEcCtD
Mitoxantrone—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000186	0.000695	CcSEcCtD
Mitoxantrone—Asthenia—Ethinyl Estradiol—osteoporosis	0.000186	0.000695	CcSEcCtD
Mitoxantrone—Nausea—Raloxifene—osteoporosis	0.000184	0.000688	CcSEcCtD
Mitoxantrone—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000183	0.000686	CcSEcCtD
Mitoxantrone—Fatigue—Conjugated Estrogens—osteoporosis	0.000182	0.000681	CcSEcCtD
Mitoxantrone—Nausea—Ibandronate—osteoporosis	0.000182	0.000681	CcSEcCtD
Mitoxantrone—Asthenia—Risedronate—osteoporosis	0.000181	0.000678	CcSEcCtD
Mitoxantrone—Feeling abnormal—Zoledronate—osteoporosis	0.000181	0.000676	CcSEcCtD
Mitoxantrone—Cough—Estradiol—osteoporosis	0.000181	0.000676	CcSEcCtD
Mitoxantrone—Constipation—Conjugated Estrogens—osteoporosis	0.00018	0.000675	CcSEcCtD
Mitoxantrone—Pain—Conjugated Estrogens—osteoporosis	0.00018	0.000675	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Zoledronate—osteoporosis	0.000179	0.000671	CcSEcCtD
Mitoxantrone—Hypertension—Estradiol—osteoporosis	0.000179	0.000668	CcSEcCtD
Mitoxantrone—Nausea—Calcitriol—osteoporosis	0.000178	0.000666	CcSEcCtD
Mitoxantrone—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000177	0.000663	CcSEcCtD
Mitoxantrone—Hypersensitivity—Pamidronate—osteoporosis	0.000177	0.000661	CcSEcCtD
Mitoxantrone—Arthralgia—Estradiol—osteoporosis	0.000176	0.000659	CcSEcCtD
Mitoxantrone—Myalgia—Estradiol—osteoporosis	0.000176	0.000659	CcSEcCtD
Mitoxantrone—Chest pain—Estradiol—osteoporosis	0.000176	0.000659	CcSEcCtD
Mitoxantrone—Anxiety—Estradiol—osteoporosis	0.000176	0.000657	CcSEcCtD
Mitoxantrone—Urticaria—Zoledronate—osteoporosis	0.000174	0.000651	CcSEcCtD
Mitoxantrone—Discomfort—Estradiol—osteoporosis	0.000174	0.000651	CcSEcCtD
Mitoxantrone—Abdominal pain—Zoledronate—osteoporosis	0.000173	0.000648	CcSEcCtD
Mitoxantrone—Body temperature increased—Zoledronate—osteoporosis	0.000173	0.000648	CcSEcCtD
Mitoxantrone—Diarrhoea—Risedronate—osteoporosis	0.000173	0.000646	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000173	0.000646	CcSEcCtD
Mitoxantrone—Asthenia—Pamidronate—osteoporosis	0.000172	0.000644	CcSEcCtD
Mitoxantrone—Confusional state—Estradiol—osteoporosis	0.00017	0.000637	CcSEcCtD
Mitoxantrone—Oedema—Estradiol—osteoporosis	0.000169	0.000632	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Estradiol—osteoporosis	0.000169	0.000632	CcSEcCtD
Mitoxantrone—Infection—Estradiol—osteoporosis	0.000168	0.000628	CcSEcCtD
Mitoxantrone—Urticaria—Conjugated Estrogens—osteoporosis	0.000168	0.000627	CcSEcCtD
Mitoxantrone—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000167	0.000624	CcSEcCtD
Mitoxantrone—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000167	0.000624	CcSEcCtD
Mitoxantrone—Shock—Estradiol—osteoporosis	0.000166	0.000622	CcSEcCtD
Mitoxantrone—Tachycardia—Estradiol—osteoporosis	0.000165	0.000617	CcSEcCtD
Mitoxantrone—Vomiting—Ethinyl Estradiol—osteoporosis	0.000165	0.000616	CcSEcCtD
Mitoxantrone—Diarrhoea—Pamidronate—osteoporosis	0.000164	0.000614	CcSEcCtD
Mitoxantrone—Skin disorder—Estradiol—osteoporosis	0.000164	0.000614	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Estradiol—osteoporosis	0.000163	0.000611	CcSEcCtD
Mitoxantrone—Rash—Ethinyl Estradiol—osteoporosis	0.000163	0.000611	CcSEcCtD
Mitoxantrone—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000163	0.00061	CcSEcCtD
Mitoxantrone—Headache—Ethinyl Estradiol—osteoporosis	0.000162	0.000607	CcSEcCtD
Mitoxantrone—Hypersensitivity—Zoledronate—osteoporosis	0.000161	0.000604	CcSEcCtD
Mitoxantrone—Vomiting—Risedronate—osteoporosis	0.000161	0.0006	CcSEcCtD
Mitoxantrone—Rash—Risedronate—osteoporosis	0.000159	0.000595	CcSEcCtD
Mitoxantrone—Dermatitis—Risedronate—osteoporosis	0.000159	0.000595	CcSEcCtD
Mitoxantrone—Headache—Risedronate—osteoporosis	0.000158	0.000592	CcSEcCtD
Mitoxantrone—Asthenia—Zoledronate—osteoporosis	0.000157	0.000588	CcSEcCtD
Mitoxantrone—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000156	0.000582	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000154	0.000576	CcSEcCtD
Mitoxantrone—Nausea—Ethinyl Estradiol—osteoporosis	0.000154	0.000575	CcSEcCtD
Mitoxantrone—Vomiting—Pamidronate—osteoporosis	0.000153	0.000571	CcSEcCtD
Mitoxantrone—Paraesthesia—Estradiol—osteoporosis	0.000152	0.000567	CcSEcCtD
Mitoxantrone—Asthenia—Conjugated Estrogens—osteoporosis	0.000151	0.000566	CcSEcCtD
Mitoxantrone—Rash—Pamidronate—osteoporosis	0.000151	0.000566	CcSEcCtD
Mitoxantrone—Dermatitis—Pamidronate—osteoporosis	0.000151	0.000565	CcSEcCtD
Mitoxantrone—Dyspnoea—Estradiol—osteoporosis	0.000151	0.000563	CcSEcCtD
Mitoxantrone—Headache—Pamidronate—osteoporosis	0.00015	0.000562	CcSEcCtD
Mitoxantrone—Somnolence—Estradiol—osteoporosis	0.00015	0.000562	CcSEcCtD
Mitoxantrone—Diarrhoea—Zoledronate—osteoporosis	0.00015	0.000561	CcSEcCtD
Mitoxantrone—Nausea—Risedronate—osteoporosis	0.00015	0.000561	CcSEcCtD
Mitoxantrone—Dyspepsia—Estradiol—osteoporosis	0.000149	0.000556	CcSEcCtD
Mitoxantrone—Decreased appetite—Estradiol—osteoporosis	0.000147	0.000549	CcSEcCtD
Mitoxantrone—Fatigue—Estradiol—osteoporosis	0.000146	0.000545	CcSEcCtD
Mitoxantrone—Constipation—Estradiol—osteoporosis	0.000144	0.00054	CcSEcCtD
Mitoxantrone—Pain—Estradiol—osteoporosis	0.000144	0.00054	CcSEcCtD
Mitoxantrone—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000144	0.00054	CcSEcCtD
Mitoxantrone—Nausea—Pamidronate—osteoporosis	0.000143	0.000533	CcSEcCtD
Mitoxantrone—Vomiting—Zoledronate—osteoporosis	0.000139	0.000521	CcSEcCtD
Mitoxantrone—Feeling abnormal—Estradiol—osteoporosis	0.000139	0.000521	CcSEcCtD
Mitoxantrone—Rash—Zoledronate—osteoporosis	0.000138	0.000517	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Estradiol—osteoporosis	0.000138	0.000517	CcSEcCtD
Mitoxantrone—Dermatitis—Zoledronate—osteoporosis	0.000138	0.000517	CcSEcCtD
Mitoxantrone—Headache—Zoledronate—osteoporosis	0.000137	0.000514	CcSEcCtD
Mitoxantrone—Vomiting—Conjugated Estrogens—osteoporosis	0.000134	0.000502	CcSEcCtD
Mitoxantrone—Urticaria—Estradiol—osteoporosis	0.000134	0.000502	CcSEcCtD
Mitoxantrone—Abdominal pain—Estradiol—osteoporosis	0.000134	0.0005	CcSEcCtD
Mitoxantrone—Body temperature increased—Estradiol—osteoporosis	0.000134	0.0005	CcSEcCtD
Mitoxantrone—Rash—Conjugated Estrogens—osteoporosis	0.000133	0.000498	CcSEcCtD
Mitoxantrone—Dermatitis—Conjugated Estrogens—osteoporosis	0.000133	0.000497	CcSEcCtD
Mitoxantrone—Headache—Conjugated Estrogens—osteoporosis	0.000132	0.000495	CcSEcCtD
Mitoxantrone—Nausea—Zoledronate—osteoporosis	0.00013	0.000487	CcSEcCtD
Mitoxantrone—Nausea—Conjugated Estrogens—osteoporosis	0.000125	0.000469	CcSEcCtD
Mitoxantrone—Hypersensitivity—Estradiol—osteoporosis	0.000124	0.000466	CcSEcCtD
Mitoxantrone—Asthenia—Estradiol—osteoporosis	0.000121	0.000453	CcSEcCtD
Mitoxantrone—Diarrhoea—Estradiol—osteoporosis	0.000116	0.000432	CcSEcCtD
Mitoxantrone—BTK—Immune System—CTSK—osteoporosis	0.000111	0.00132	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—NFATC1—osteoporosis	0.000109	0.0013	CbGpPWpGaD
Mitoxantrone—Vomiting—Estradiol—osteoporosis	0.000107	0.000402	CcSEcCtD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	0.000107	0.00128	CbGpPWpGaD
Mitoxantrone—Rash—Estradiol—osteoporosis	0.000107	0.000398	CcSEcCtD
Mitoxantrone—Dermatitis—Estradiol—osteoporosis	0.000106	0.000398	CcSEcCtD
Mitoxantrone—Headache—Estradiol—osteoporosis	0.000106	0.000396	CcSEcCtD
Mitoxantrone—ABCB1—HIF-1-alpha transcription factor network—LEP—osteoporosis	0.000105	0.00125	CbGpPWpGaD
Mitoxantrone—CYP2E1—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000105	0.00125	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—PSMA2—osteoporosis	0.000104	0.00124	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—PSMA5—osteoporosis	0.000104	0.00124	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	0.000104	0.00124	CbGpPWpGaD
Mitoxantrone—ABCG2—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000103	0.00122	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—AGER—osteoporosis	0.000102	0.00121	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—ADCY5—osteoporosis	0.000101	0.00121	CbGpPWpGaD
Mitoxantrone—BTK—Regulation of toll-like receptor signaling pathway—IL6—osteoporosis	0.000101	0.0012	CbGpPWpGaD
Mitoxantrone—Nausea—Estradiol—osteoporosis	0.0001	0.000375	CcSEcCtD
Mitoxantrone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	9.99e-05	0.00119	CbGpPWpGaD
Mitoxantrone—BTK—Toll-Like Receptors Cascades—IL6—osteoporosis	9.99e-05	0.00119	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	9.94e-05	0.00118	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—SOST—osteoporosis	9.94e-05	0.00118	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PKM—osteoporosis	9.94e-05	0.00118	CbGpPWpGaD
Mitoxantrone—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	9.86e-05	0.00118	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—ANTXR2—osteoporosis	9.42e-05	0.00112	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PGLS—osteoporosis	9.42e-05	0.00112	CbGpPWpGaD
Mitoxantrone—CYP2E1—Biological oxidations—CYP19A1—osteoporosis	9.27e-05	0.00111	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metapathway biotransformation—CYP19A1—osteoporosis	9.15e-05	0.00109	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	9.12e-05	0.00109	CbGpPWpGaD
Mitoxantrone—TOP2A—Mitotic G1-G1/S phases—MYC—osteoporosis	8.94e-05	0.00107	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—PSMA2—osteoporosis	8.89e-05	0.00106	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—PSMA5—osteoporosis	8.89e-05	0.00106	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—IRS2—osteoporosis	8.86e-05	0.00106	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 signaling—IL6—osteoporosis	8.85e-05	0.00105	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	8.83e-05	0.00105	CbGpPWpGaD
Mitoxantrone—CYP1B1—Biological oxidations—POMC—osteoporosis	8.53e-05	0.00102	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—IRS2—osteoporosis	8.5e-05	0.00101	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 interactions—IL6—osteoporosis	8.33e-05	0.000992	CbGpPWpGaD
Mitoxantrone—BTK—Fc epsilon receptor (FCERI) signaling—IL6—osteoporosis	8.33e-05	0.000992	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—FDPS—osteoporosis	8.32e-05	0.000992	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PKM—osteoporosis	8.32e-05	0.000992	CbGpPWpGaD
Mitoxantrone—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	8.19e-05	0.000976	CbGpPWpGaD
Mitoxantrone—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	8.1e-05	0.000965	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	8.08e-05	0.000963	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PKM—osteoporosis	8.05e-05	0.000959	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—FDPS—osteoporosis	8.05e-05	0.000959	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—GSN—osteoporosis	8.01e-05	0.000954	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—GPD2—osteoporosis	7.89e-05	0.00094	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PGLS—osteoporosis	7.89e-05	0.00094	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—IRS1—osteoporosis	7.73e-05	0.000921	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PGLS—osteoporosis	7.63e-05	0.000909	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—GPD2—osteoporosis	7.63e-05	0.000909	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—KL—osteoporosis	7.53e-05	0.000897	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—IRS1—osteoporosis	7.42e-05	0.000885	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PKM—osteoporosis	7.32e-05	0.000873	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—FDPS—osteoporosis	7.32e-05	0.000873	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—IL6R—osteoporosis	7.26e-05	0.000865	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—ATIC—osteoporosis	7.21e-05	0.00086	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PNP—osteoporosis	7.21e-05	0.00086	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	7.07e-05	0.000843	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PNP—osteoporosis	6.98e-05	0.000832	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—ATIC—osteoporosis	6.98e-05	0.000832	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—LRP5—osteoporosis	6.97e-05	0.00083	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PGLS—osteoporosis	6.94e-05	0.000827	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—GPD2—osteoporosis	6.94e-05	0.000827	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	6.78e-05	0.000808	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	6.76e-05	0.000806	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—LRP6—osteoporosis	6.66e-05	0.000794	CbGpPWpGaD
Mitoxantrone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—osteoporosis	6.63e-05	0.00079	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—RPL24—osteoporosis	6.4e-05	0.000763	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—LTF—osteoporosis	6.4e-05	0.000763	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—ATIC—osteoporosis	6.35e-05	0.000757	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PNP—osteoporosis	6.35e-05	0.000757	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	6.31e-05	0.000752	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—OXCT1—osteoporosis	6.13e-05	0.000731	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—CA2—osteoporosis	6.13e-05	0.000731	CbGpPWpGaD
Mitoxantrone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	6.01e-05	0.000716	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—MGLL—osteoporosis	5.98e-05	0.000712	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—CA2—osteoporosis	5.93e-05	0.000707	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—OXCT1—osteoporosis	5.93e-05	0.000707	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—AGER—osteoporosis	5.92e-05	0.000705	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—ADCY5—osteoporosis	5.89e-05	0.000703	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—IL1B—osteoporosis	5.8e-05	0.000692	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—MGLL—osteoporosis	5.78e-05	0.000689	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	5.64e-05	0.000672	CbGpPWpGaD
Mitoxantrone—CYP2E1—Biological oxidations—POMC—osteoporosis	5.57e-05	0.000664	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—ANXA2—osteoporosis	5.55e-05	0.000662	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—ACP5—osteoporosis	5.55e-05	0.000662	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	5.45e-05	0.00065	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—OXCT1—osteoporosis	5.4e-05	0.000643	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—CA2—osteoporosis	5.4e-05	0.000643	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—MGLL—osteoporosis	5.26e-05	0.000627	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PKM—osteoporosis	5.26e-05	0.000627	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—FDPS—osteoporosis	5.26e-05	0.000627	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—TPI1—osteoporosis	5.16e-05	0.000615	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—IRS2—osteoporosis	5.16e-05	0.000615	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—IDH2—osteoporosis	5.08e-05	0.000606	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—GPD2—osteoporosis	4.98e-05	0.000594	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PGLS—osteoporosis	4.98e-05	0.000594	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—IDH2—osteoporosis	4.92e-05	0.000586	CbGpPWpGaD
Mitoxantrone—TOP2A—Circadian rythm related genes—IL6—osteoporosis	4.89e-05	0.000583	CbGpPWpGaD
Mitoxantrone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	4.87e-05	0.00058	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—P4HB—osteoporosis	4.85e-05	0.000578	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—CYP27A1—osteoporosis	4.78e-05	0.00057	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—GAPDH—osteoporosis	4.76e-05	0.000568	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—ACP5—osteoporosis	4.65e-05	0.000554	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—CYP27A1—osteoporosis	4.62e-05	0.000551	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	4.59e-05	0.000547	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PNP—osteoporosis	4.56e-05	0.000543	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ATIC—osteoporosis	4.56e-05	0.000543	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—NFATC1—osteoporosis	4.53e-05	0.000539	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—TGFB1—osteoporosis	4.51e-05	0.000538	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—IRS1—osteoporosis	4.5e-05	0.000537	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—ACP5—osteoporosis	4.5e-05	0.000536	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—DKK1—osteoporosis	4.49e-05	0.000535	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—IDH2—osteoporosis	4.47e-05	0.000533	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	4.44e-05	0.000529	CbGpPWpGaD
Mitoxantrone—ABCC1—Transmembrane transport of small molecules—ADCY5—osteoporosis	4.38e-05	0.000522	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—WNT1—osteoporosis	4.32e-05	0.000515	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—TPI1—osteoporosis	4.32e-05	0.000515	CbGpPWpGaD
Mitoxantrone—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	4.3e-05	0.000513	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	4.29e-05	0.000511	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	4.24e-05	0.000506	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—IL6R—osteoporosis	4.23e-05	0.000504	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—TNF—osteoporosis	4.21e-05	0.000502	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—FGA—osteoporosis	4.21e-05	0.000501	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—CYP27A1—osteoporosis	4.21e-05	0.000501	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—TPI1—osteoporosis	4.18e-05	0.000498	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—ACP5—osteoporosis	4.09e-05	0.000488	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—P4HB—osteoporosis	4.06e-05	0.000484	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—GAPDH—osteoporosis	3.99e-05	0.000475	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PKM—osteoporosis	3.96e-05	0.000472	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—FDPS—osteoporosis	3.96e-05	0.000472	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—P4HB—osteoporosis	3.93e-05	0.000468	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—RAP1A—osteoporosis	3.88e-05	0.000463	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—OXCT1—osteoporosis	3.88e-05	0.000462	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CA2—osteoporosis	3.88e-05	0.000462	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—GAPDH—osteoporosis	3.86e-05	0.00046	CbGpPWpGaD
Mitoxantrone—ABCG2—Transmembrane transport of small molecules—ADCY5—osteoporosis	3.85e-05	0.000459	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—TPI1—osteoporosis	3.8e-05	0.000453	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—MGLL—osteoporosis	3.78e-05	0.00045	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—RAP1A—osteoporosis	3.76e-05	0.000448	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PGLS—osteoporosis	3.75e-05	0.000447	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—GPD2—osteoporosis	3.75e-05	0.000447	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—ENO1—osteoporosis	3.75e-05	0.000447	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	3.71e-05	0.000442	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PSMA5—osteoporosis	3.69e-05	0.00044	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PSMA2—osteoporosis	3.69e-05	0.00044	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—P4HB—osteoporosis	3.58e-05	0.000426	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—GAPDH—osteoporosis	3.51e-05	0.000418	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—CALCA—osteoporosis	3.44e-05	0.00041	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ATIC—osteoporosis	3.43e-05	0.000409	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PNP—osteoporosis	3.43e-05	0.000409	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—RAP1A—osteoporosis	3.42e-05	0.000407	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	3.39e-05	0.000404	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle, Mitotic—MYC—osteoporosis	3.28e-05	0.000391	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	3.28e-05	0.000391	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—IL6—osteoporosis	3.23e-05	0.000386	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—IL1B—osteoporosis	3.22e-05	0.000383	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—IDH2—osteoporosis	3.21e-05	0.000383	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—ENO1—osteoporosis	3.14e-05	0.000374	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—KL—osteoporosis	3.13e-05	0.000373	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PSMA5—osteoporosis	3.09e-05	0.000369	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PSMA2—osteoporosis	3.09e-05	0.000369	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—ENO1—osteoporosis	3.04e-05	0.000362	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CYP27A1—osteoporosis	3.02e-05	0.00036	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PSMA2—osteoporosis	2.99e-05	0.000357	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PSMA5—osteoporosis	2.99e-05	0.000357	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ACP5—osteoporosis	2.94e-05	0.00035	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—MYC—osteoporosis	2.93e-05	0.00035	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CA2—osteoporosis	2.92e-05	0.000348	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—OXCT1—osteoporosis	2.92e-05	0.000348	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—MGLL—osteoporosis	2.84e-05	0.000339	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—ENO1—osteoporosis	2.76e-05	0.000329	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—TPI1—osteoporosis	2.73e-05	0.000325	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PSMA5—osteoporosis	2.72e-05	0.000325	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PSMA2—osteoporosis	2.72e-05	0.000325	CbGpPWpGaD
Mitoxantrone—CYP3A4—Biological oxidations—POMC—osteoporosis	2.59e-05	0.000308	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—P4HB—osteoporosis	2.57e-05	0.000306	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—GAPDH—osteoporosis	2.52e-05	0.0003	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—CYP19A1—osteoporosis	2.51e-05	0.000299	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—RAP1A—osteoporosis	2.45e-05	0.000293	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—ADCY5—osteoporosis	2.45e-05	0.000292	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—FDPS—osteoporosis	2.44e-05	0.000291	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PKM—osteoporosis	2.44e-05	0.000291	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—CYP19A1—osteoporosis	2.43e-05	0.000289	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—IDH2—osteoporosis	2.42e-05	0.000288	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PGLS—osteoporosis	2.31e-05	0.000276	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GPD2—osteoporosis	2.31e-05	0.000276	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CYP27A1—osteoporosis	2.27e-05	0.000271	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—MTHFR—osteoporosis	2.25e-05	0.000268	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	2.23e-05	0.000266	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	2.23e-05	0.000265	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ACP5—osteoporosis	2.21e-05	0.000264	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—CYP19A1—osteoporosis	2.21e-05	0.000263	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—IRS2—osteoporosis	2.14e-05	0.000255	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ATIC—osteoporosis	2.11e-05	0.000252	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PNP—osteoporosis	2.11e-05	0.000252	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	2.08e-05	0.000248	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	2.08e-05	0.000248	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—TPI1—osteoporosis	2.06e-05	0.000245	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—ADCY5—osteoporosis	2.05e-05	0.000244	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—GPX1—osteoporosis	2.04e-05	0.000244	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ENO1—osteoporosis	1.98e-05	0.000236	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—ADCY5—osteoporosis	1.98e-05	0.000236	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—GPX1—osteoporosis	1.98e-05	0.000236	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PSMA2—osteoporosis	1.95e-05	0.000233	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PSMA5—osteoporosis	1.95e-05	0.000233	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—P4HB—osteoporosis	1.93e-05	0.00023	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—GAPDH—osteoporosis	1.9e-05	0.000226	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—MTHFR—osteoporosis	1.89e-05	0.000225	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—IL6—osteoporosis	1.88e-05	0.000225	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—IRS1—osteoporosis	1.87e-05	0.000223	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—RAP1A—osteoporosis	1.85e-05	0.00022	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—MTHFR—osteoporosis	1.82e-05	0.000217	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—ADCY5—osteoporosis	1.8e-05	0.000215	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—GPX1—osteoporosis	1.8e-05	0.000214	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CA2—osteoporosis	1.8e-05	0.000214	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—OXCT1—osteoporosis	1.8e-05	0.000214	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—IL6R—osteoporosis	1.76e-05	0.000209	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—MGLL—osteoporosis	1.75e-05	0.000209	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—MTHFR—osteoporosis	1.66e-05	0.000198	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CYP19A1—osteoporosis	1.59e-05	0.000189	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—POMC—osteoporosis	1.51e-05	0.00018	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ENO1—osteoporosis	1.49e-05	0.000178	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—IDH2—osteoporosis	1.49e-05	0.000178	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PSMA5—osteoporosis	1.47e-05	0.000175	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PSMA2—osteoporosis	1.47e-05	0.000175	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—POMC—osteoporosis	1.46e-05	0.000174	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.4e-05	0.000167	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ACP5—osteoporosis	1.36e-05	0.000162	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—POMC—osteoporosis	1.33e-05	0.000158	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ADCY5—osteoporosis	1.3e-05	0.000154	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—GPX1—osteoporosis	1.29e-05	0.000154	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—TPI1—osteoporosis	1.27e-05	0.000151	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CYP19A1—osteoporosis	1.19e-05	0.000142	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—MTHFR—osteoporosis	1.19e-05	0.000142	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—P4HB—osteoporosis	1.19e-05	0.000142	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GAPDH—osteoporosis	1.17e-05	0.000139	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—RAP1A—osteoporosis	1.14e-05	0.000136	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—MYC—osteoporosis	1.04e-05	0.000124	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—TGFB1—osteoporosis	1.04e-05	0.000124	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ADCY5—osteoporosis	9.76e-06	0.000116	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—GPX1—osteoporosis	9.73e-06	0.000116	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—POMC—osteoporosis	9.53e-06	0.000114	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ENO1—osteoporosis	9.2e-06	0.00011	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PSMA2—osteoporosis	9.07e-06	0.000108	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PSMA5—osteoporosis	9.07e-06	0.000108	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—MTHFR—osteoporosis	8.98e-06	0.000107	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—IL6—osteoporosis	7.83e-06	9.33e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CYP19A1—osteoporosis	7.36e-06	8.77e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—POMC—osteoporosis	7.18e-06	8.55e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ADCY5—osteoporosis	6.01e-06	7.17e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GPX1—osteoporosis	5.99e-06	7.14e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—MTHFR—osteoporosis	5.53e-06	6.59e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—POMC—osteoporosis	4.42e-06	5.27e-05	CbGpPWpGaD
